Download Free Medical United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 2 PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Presented in six separate booklets, United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 gives detailed information and analysis to support the international community in implementing operational recommendations present in the outcome document of the special session of the General Assembly on the world drug problem, held in 2016 Booklet 2 of the United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 focuses on drug demand. It contains a worldwide overview of the extent of and trends in drug use, including drug use disorders, and its health consequences.

Tags : United Nations Office on Drugs and Crime, UNODC, summary, World Drug Report 2020, General Assembly, world drug problem, drug use, drug use disorders

Published on : Jun 30, 2020 | Views : 2598 | Downloads : 2

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

25 June 2020 World Drug Report 2020: Drug use and health consequences
Slide 2-

Global numbers of people using drugs 2018
Slide 3-

Prevalence of drug use and drug use disorders, 2006–2018 Number of people who use drugs and people with drug use disorders, 2006–2018 Drug use has been on the rise - both overall numbers and the proportion of the world’s population Increased far more rapidly in developing countries though more widespread in developed countries
Slide 4-

Global and regional use of cannabis Use of cannabis among general population aged 15–64, 2018 Use of cannabis among people aged 15–16, and general population aged 15–64, 2018 Source: UNODC, responses to the annual report questionnaire; and other government reports. Note: The estimates of the annual prevalence of use among those aged 15–16 are based on school surveys in most countries and may not be representative of all those.
Slide 5-

Trends in cannabis use, United States, 2002–2018 Trends in cannabis use, by age group, United States, 2002–2018 Cannabis use in the Americas has been increasing over the past decade
Slide 6-

Trends in cannabis use, Uruguay, 2001–2018 Cannabis use, by gender and age group, Plurinational State of Bolivia, 2018 Cannabis use in South America
Slide 7-

Trends in cannabis use, selected countries in Western and Central Europe, 2004–2018 Cannabis use in Western and Central Europe is increasing, in particular in some countries with large populations
Slide 8-

Opioids cause the greatest harm to the health of users Source: UNODC, responses to the annual report questionnaire Use of opioids and opiates, by region and subregion, 2018
Slide 9-

Most commonly used opioid, 2018 or latest available data
Slide 10-

Main stimulant drug used, 2018 or latest year
Slide 11-

Source: UNODC, responses to the annual report questionnaire. Note: “Amphetamines” includes the non-medical use of amphetamine, methamphetamine and pharmaceutical stimulants. Use of amphetamines seems to be increasing in North America Number of people using amphetamines appears stable in Western and Central Europe but the level of consumption seems to be increasing Methamphetamine use remains of concern in East and South-East Asia Wastewater analysis shows an increase in methamphetamine use in Australia and New Zealand Use of amphetamines, especially methamphetamine, is increasing in parts of Asia and North America
Slide 12-

Forms of “ecstasy” have diversified, with a high MDMA content available on the main markets
Slide 13-

Indications of increasing cocaine use in Western and Central Europe and mixed trends in the Americas Use of cocaine is stabilizing in North America Mixed trends in cocaine use in South America Despite a high prevalence of cocaine use, the quantities of cocaine consumed in Australia and New Zealand are small as use is sporadic
Slide 14-

Trends in the primary drug of concern in drug treatment, by region and selected subregions, 2003, 2009, 2014 and 2018 Availability of and access to treatment services remains limited at the global level, as only one in eight people with drug use disorders receives drug treatment each year. While one in three drug users is a woman, they continue to account for only one in five or more people in treatment.
Slide 15-

Drug use accounts for 42 million DALYs 58500 deaths Opioids account for half of DALYs Source: Institute for Health Metrics and Evaluation, “Global Burden of Disease Study 2017 (GBD 2017) Data Resources: GBD Results Tools”, 2018.
Slide 16-

More than 11 million people inject drugs and 1.4 million living with HIV
Slide 17-

Estimated sub-regional prevalence of hepatitis C (HCV) and hepatitis B (HBV) among PWID, 2018 5.5 million PWID living with HCV 1.2 million PWID living with HIV and HCV
Slide 18-

More than 11 million people inject drugs and 1.4 million living with HIV

User Presentation
Related Presentations

Medicare Part D Prescription Drug Benefit Overview

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

Medicare Part D Prescription Drug Benefit Overview

The financialisation of Big Pharma

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 1

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 2

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.5

Antimicrobial Stewardship

Challenges in Personalised Medicine

About Pharmacoeconomics

Value of Personalized Medicine

Drug Supply Management

HEALTH A TO Z